AstraZeneca (LON:AZN) Hits New 1-Year Low at $105.92

AstraZeneca PLC (LON:AZN - Get Free Report) reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as GBX 105.92 ($1.34) and last traded at £106.86 ($135.25), with a volume of 212246 shares trading hands. The stock had previously closed at £106.10 ($134.29).

Analyst Upgrades and Downgrades

AZN has been the subject of a number of analyst reports. Berenberg Bank restated a "buy" rating on shares of AstraZeneca in a research note on Wednesday, March 13th. Jefferies Financial Group reaffirmed a "hold" rating and issued a £110 ($139.22) target price on shares of AstraZeneca in a report on Friday, February 16th. Shore Capital reiterated a "buy" rating on shares of AstraZeneca in a research report on Friday. UBS Group cut their target price on shares of AstraZeneca from £107 ($135.43) to GBX 9,900 ($125.30) and set a "sell" rating on the stock in a research report on Monday, February 12th. Finally, Barclays restated an "overweight" rating and set a £125 ($158.21) target price on shares of AstraZeneca in a research report on Monday. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, AstraZeneca currently has an average rating of "Moderate Buy" and an average price target of £115.88 ($146.66).

AstraZeneca Stock Performance

The stock has a market capitalization of £165.97 billion, a price-to-earnings ratio of 3,545.70, a price-to-earnings-growth ratio of 0.87 and a beta of 0.17. The company has a 50 day simple moving average of £102.92 and a 200-day simple moving average of £104.29. The company has a quick ratio of 0.59, a current ratio of 0.82 and a debt-to-equity ratio of 75.70.

AstraZeneca Increases Dividend

The company also recently disclosed a dividend, which was paid on Monday, March 25th. Stockholders of record on Thursday, February 22nd were issued a dividend of GBX 156 ($1.97) per share. This is an increase from AstraZeneca's previous dividend of $71.80. The ex-dividend date of this dividend was Thursday, February 22nd. This represents a dividend yield of 1.49%. AstraZeneca's payout ratio is currently 7,549.67%.

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.